Search filters

List of works by Andrea Harrer

A routine-qualified flow cytometric method for the identification of multiple sclerosis patients with a reduced therapeutic effectiveness of natalizumab

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod

scientific article published on 10 September 2015

Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment

scientific article published on 11 October 2010

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations

scientific article published in 2016

Basophil activation test for investigation of IgE-mediated mechanisms in drug hypersensitivity

scientific article published on 16 September 2011

Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases

scientific article published on 02 November 2019

CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells

scientific article published on July 2016

Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy

scientific article published on 23 October 2012

Characterization of plant food allergens: an overview on physicochemical and immunological techniques

scientific article published on January 2010

Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction

scientific article published on 24 February 2020

Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis

scientific article published on 9 August 2012

Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention

scientific article

Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies

scientific article

Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites

scientific article

Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels

scientific article published on 12 February 2016

Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis

scientific article

High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis

scientific article

High-dose intravenous interferon-beta in multiple sclerosis patients with high-titer neutralizing antibodies (HINABS II) - A pilot study

scientific article

Human Cerebrospinal Fluid Promotes Neuronal Viability and Activity of Hippocampal Neuronal Circuits In Vitro

scientific article published on 4 March 2016

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome

scientific article published on 11 October 2016

Isoform identification and characterization of Art v 3, the lipid-transfer protein of mugwort pollen.

scientific article published on 29 April 2009

Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy

scientific article published on 26 December 2011

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis

scientific article (publication date: 2012)

Molecular characterization of Api g 2, a novel allergenic member of the lipid-transfer protein 1 family from celery stalks

scientific article published on 20 December 2010

Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies

scientific article published on 30 September 2011

Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?

scientific article published on 30 August 2013

Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells

scientific article published on 29 March 2011

Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options

scientific article

Reshaping the Bet v 1 fold modulates T(H) polarization.

scientific article published on 21 March 2011

Routine-taugliche durchflusszytometrische Methode zur Identifikation von Multiple Sklerose PatientInnen mit einer nicht ausreichenden Therapieeffizienz unter einer Natalizumab-Therapie

Serial flow cytometric analyses of blood and cerebrospinal fluid in natalizumab-associated progressive multifocal leukencephalopathy with an excellent outcome

TaqManR proximity ligation technology for the detection of heterodimeric adhesion receptors on lymphocytes

scientific article published on December 2013

The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions

scientific article published on 19 December 2016

Therapeutisches Drug-Monitoring der Natalizumab-Sättigung von Immunzellen mittels Durchflusszytometrie bei Multipler Sklerose/Flow cytometry and drug monitoring of natalizumab saturation of immune cells in multiple sclerosis

Tumefactive MS lesions under fingolimod: a case report and literature review

scientific article

Zukünftiger Stellenwert von Liquor-Biomarker in der modernen MS-Therapie/Future relevance of CSF biomarkers in modern MS treatment

Übersicht über Labormethoden zur Überwachung innovativer Therapieregimes bei Multipler Sklerose/Overview of laboratory methods to monitor innovative treatment regimens in multiple sclerosis

Paulina is supported by:

About Paulina

Help